CROI 2015: Addressing HIV and Cardiovascular Issues (Video)
April 24, 2015
Fred Schaich of IFARA spoke to a panel of researchers and funders about cardiovascular issues in HIV and studies addressing them. The discussion focused on the upcoming Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), which will try to "come up once and for all with a prevention strategy for cardiac disease in HIV," said Steven K. Grinspoon, M.D. He further explained that infarction rates in people living with HIV are 50-75% higher than in the general population, possibly as a result of accelerated aging due to HIV-induced ongoing inflammation. The study is funded by the U.S. National Heart, Lung, and Blood Institute, which considers the inclusion of diverse populations, in particular women, "critical," according to Monica Shah, M.D.
Other research discussed included two predictive studies, one to predict cardiovascular outcome in individual patients, and the other to predict cardiovascular disease rates. Panel members agreed that lifestyle issues, such as smoking, lack of exercise and an unhealthy diet, worsen HIV-positive patients' already higher risk for heart problems.
Watch the video to learn more:
About the panelists:
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
Copyright © 2015 Remedy Health Media, LLC. All rights reserved.
This article was provided by TheBodyPRO. It is a part of the publication The 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015).
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.